UPC_CoA_646/2025

METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

BerufungenHauptberufungCourt of AppealAppealCase Closed

Parteien

Amgen NV, Amgen NV, Amgen NV, Amgen NV, Amgen NV, Amgen NV, Amgen NVvRegeneron Pharmaceuticals Inc.

Richter

Patente

CPC-Codes: A61K39/3955, C07K2317/76, A61P9/00, A61P43/00, A61P27/02, C07K2317/21, A61P7/00, C07K16/40, A61K2039/505, A61P11/00, A61P3/06, A61P9/10

Sektor: Organic Chemistry

Ausgang

—

Eingereicht: 11. Juli 2025

Erste Entscheidung: —

Sprache: English